Avadel Cns Pharmaceuticals, LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.4Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
5,298clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2020 $15K
2023 $352K
2024 $1.5M
2025 $1.6M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $857K
Sleep Medicine (Internal Medicine) $676K
Sleep Medicine (Psychiatry & Neurology) $378K
Pulmonary Disease $278K
Neurology With Special Qualifications In Child Neurology $220K
Family $200K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Jordan Dubow Suffern, NY Neurology (Psychiatry & Neurology) $286,407.92
Steven Gradney Springfield, MO Sleep Medicine (Internal Medicine) $248,109.77
Alon Avidan Los Angeles, CA Neurology (Psychiatry & Neurology) $178,651.22
Anne Morse Danville, PA Neurology With Special Qualifications In Child Neurology $147,272.39
Gerard Meskill Sugar Land, TX Sleep Medicine (Psychiatry & Neurology) $129,765.62
Lewis Kass Philadelphia, PA Pediatric Pulmonology $111,391.83
Matthew Davis Middletown, NJ Neurology (Psychiatry & Neurology) $108,212.45
Mark Mccamish Ventura, CA Internal Medicine $93,372.87
Murad Assaad Atlanta, GA Sleep Medicine (Internal Medicine) $83,262.95
Laura Herpel Columbia, SC Pulmonary Disease $80,649.35

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.